Tran L L - OmicsDI

Show results for

Unknown (3297)
Transcriptomics (163)
Proteomics (92)
Genomics (23)
Metabolomics (15)
Models (5)

Organisms

Homo sapiens (126)
Mus musculus (55)
Arabidopsis thaliana (24)
Saccharomyces cerevisiae (7)
Escherichia coli (5)
Streptomyces coelicolor A3(2) (4)
Escherichia coli str. K-12 substr. MG1655 (4)
groundwater metagenome (3)
Glycine max (3)
Drosophila melanogaster (3)
Bos taurus (2)
Rattus (1)
Secale cereale x Triticum turgidum subsp. durum (1)
Saccharomyces cerevisiae BY4741 (1)
uncultured organism (1)
Macaca mulatta (1)
Daphnia magna (1)
Schistosoma mansoni (1)
Zea mays (1)
Staphylococcus aureus (1)
Escherichia coli K-12 (1)
Eremophila rugosa (1)
Crocus sativus (1)
Pseudomonas putida KT2440 (1)
Rhodotorula toruloides (1)
Severe acute respiratory syndrome coronavirus 2 (1)
Aspergillus nidulans (1)
Brachylophosaurus canadensis (1)
Chlorocebus aethiops (1)
Dengue virus (1)

Organisms

Sorghum x drummondii (2)
Sus scrofa (1)
Homo sapiens (1)

Repository

biostudies-arrayexpress (167)
pride (72)
MassIVE (13)
MetaboLights (12)
EGA (11)
ENA (7)
BioModels (5)
PanoramaPublic (4)
GNPS (3)
iProX (2)
geo (1)
jPOST (1)

Tissue

Epithelial cell (12)
Cell culture (10)
Brain (7)
Permanent cell line cell (4)
B cell (3)
Blood plasma (3)
Breast cancer cell (3)
Pancreas (3)
Blood (2)
Blood serum (2)
Breast epithelial cell (2)
Cell line cell (2)
Cell suspension culture (2)
Colon (2)
HEK-293 cell (2)
Hepatocyte (2)
Liver (2)
Salivary gland (2)
Blood vessel (1)
Breast epithelium (1)
Cervical epithelial cell (1)
Fibroblast (1)
Leaf (1)
Monocyte (1)
Myoblast (1)
Peripheral blood mononuclear cell (1)
Plant cell (1)
Pollen (1)
Retina (1)
Spleen (1)

Disease

Breast cancer (5)
Disease free (3)
Cervix carcinoma (2)
Colon cancer (2)
Dengue disease (2)
Dengue hemorrhagic fever (2)
Dengue shock syndrome (2)
Severe COVID-19 (2)
Carotid artery disease: ASYMPTOMATIC high-grade inner carotid artery stenosis (1)
HIV-Tuberculosis with Immune Reconstitution Inflammatory Syndrome (1)
Melanoma (1)
Prostate cancer (1)
Acute leukemia (1)
Alzheimer's disease 1 (1)
Brain glioblastoma multiforme (1)
Diffuse large B-cell lymphoma (1)
Duchenne muscular dystrophy (1)
Hepatitis C (1)
Inflammatory bowel disease (1)
Long COVID (1)
Lung cancer (1)
Multiple myeloma (1)
Pancreatic cancer (1)
Pancreatic ductal adenocarcinoma (1)
Parkinson's disease (1)
Prostate adenocarcinoma (1)
Susceptibility to dengue virus (1)
Temporal lobe epilepsy (1)

Technology Type

Mass Spectrometry (72)
Shotgun proteomics (33)
Bottom-up proteomics (15)
Data-dependent acquisition (12)
Mass spectrometry (10)
Affinity purification coupled with mass spectrometry proteomics (9)
Gel-based experiment (6)
SWATH MS (5)
Mass spectrometry assay (3)
Data-independent acquisition (3)
SRM/MRM (3)
NMR spectroscopy (2)
Affinity proteomics (2)
Affymetrix/Illumina (1)
Illumina MiSeq, ILLUMINA (1)
All-ion fragmentation (1)
DiaPASEF (1)
MSE (1)
Metaproteomics (1)
Olink affinity proteomics (1)
Top-down proteomics (1)

Instrument Platform

DNA Microarray Scanner BA [Agilent Technologies] (4)
LTQ (4)
Liquid Chromatography MS - negative - reverse phase (4)
Liquid Chromatography MS - positive - reverse phase (4)
Q Exactive (3)
Illumina HiSeq 2500 (2)
Illumina NovaSeq 6000 (2)
Exactive (Thermo Scientific) (2)
Gas Chromatography MS - positive (2)
Nuclear Magnetic Resonance (NMR) - (2)
Agilent 210 BioAnalyzer (1)
Spectronic Helios Alpha UV-Vis spectrophotometer (1)
Illumina Genome Analyzer II (1)
NextSeq 2000 (1)
Illumina HiSeq 1000 (1)
Illumina MiSeq (1)
Illumina HiSeq 2000 (1)
Illumina HiSeq 3000 (1)
NextSeq 500 (1)
MicrOTOF II (1)
Q Exactive UHMR (1)
LTQ Orbitrap (1)
Orbitrap Exploris 480 (1)
Orbitrap Fusion ETD (1)
Orbitrap Fusion Lumos (1)
Q Exactive HF-X (1)
Q Exactive Plus (1)
TSQ Quantiva (1)
TripleTOF 6600 (1)
Direct infusion MS - alternating (1)

Publication Date

2013 (28)
2012 (28)
2015 (21)
2023 (20)
2016 (18)
2011 (17)
2014 (16)
2026 (15)
2010 (14)
2024 (13)
2025 (13)
2021 (12)
2020 (11)
2022 (10)
2019 (7)
2017 (6)
2008 (6)
2007 (6)
2018 (6)
2005 (5)
2009 (3)
2006 (1)
2004 (1)
2002 (1)

UNIPROT ID/AC

O54910 (1)
O88351 (1)
O88522 (1)
P25799 (1)
Q60680 (1)
Q60778 (1)
Q9Z1E3 (1)

CHEBI ID

CHEBI:15428 (6)
CHEBI:16610 (5)
CHEBI:17822 (5)
CHEBI:18012 (5)
CHEBI:25017 (5)
CHEBI:28790 (5)
CHEBI:33508 (5)
CHEBI:15741 (4)
CHEBI:15891 (4)
CHEBI:15940 (4)
CHEBI:16113 (4)
CHEBI:16449 (4)
CHEBI:16737 (4)
CHEBI:16811 (4)
CHEBI:16958 (4)
CHEBI:17148 (4)
CHEBI:17754 (4)
CHEBI:18186 (4)
CHEBI:18237 (4)
CHEBI:18257 (4)
CHEBI:18295 (4)
CHEBI:22653 (4)
CHEBI:24898 (4)
CHEBI:25094 (4)
CHEBI:26271 (4)
CHEBI:27266 (4)
CHEBI:27570 (4)
CHEBI:28044 (4)
CHEBI:28300 (4)
CHEBI:29016 (4)

Metabolite Name

10-oxo-nonadecanoic acid (2)
10E,16-heptadecadien-8-ynoic acid (2)
15-HETE (2)
2'-deoxycytidine (2)
2'-deoxyinosine (2)
3,5,7,9,11-dodecapentaenoic acid (2)
3-(3,4-dimethyl-5-pentylfuran-2-yl)-propanoic acid (2)
3-carboxy-4-methyl-5-pentyl-2-furanpropanoic acid (2)
4E,6E,10Z-Hexadecatrien-1-ol (2)
Adenosine (2)
Aldosterone (2)
Androsterone (2)
Behenic acid (2)
Butyl 3-O-beta-D-glucopyranosyl-butanoate (2)
C17 sphingosine-1-phosphocholine (2)
Cholic acid (2)
Choline (2)
Creatine (2)
Diethyl phthalate (2)
Disopyramide (2)
Gabapentin (2)
Glycerophosphocholine (2)
Guanidinopropionic acid (2)
Indoleacetic acid (2)
Inosine (2)
Isoguanosine (2)
L-Glutamate (2)
L-Histidine (2)
Limonene-1,2-epoxide (2)
Malonic acid (2)

First Public Date

2024 (2)
2025 (1)
2023 (1)
2021 (1)
2019 (1)
2015 (1)

Modelling Approach

Ordinary differential equation model (5)

Lab affiliation

1) Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX 77030, USA 2) Proteomics Core Facility, Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX 77030, USA 3) Metabolomics Core Facility, Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX 77030, USA (2)
Bioinformatics Solutions Inc., Waterloo, Ontario, Canada (2)
Director, Translational Proteomics Research Unit, IRCM Director, Biomarker Pipeline for Precision Medicine Strategic Initiative Full IRCM Research Professor Full Research Professor, Department of Biochemistry and Molecular Medicine (accreditation for the Molecular Biology Programs), Université de Montréal Holder of the Bell-Bombardier Chair of Excellence Person in charge of responsible conduct of research, IRCM (2)
Division of Surgery, Oncology, and Pathology, Department of Clinical Sciences. Biomedical Center – Lund University, Solvegatan 19, 223 62, Lund, Sweden (2)
Institute of Clinical Pharmacology, Goethe-University, Frankfurt am Main, Germany (2)
Molecular Biology and the Lewis-Sigler Institute for Integrative Genomics, Princeton University, USA (2)
University of the Pacific (2)
1. Garvan Institute of Medical Research, Cancer Ecosystems Program, and The Kinghorn Cancer Centre, Darlinghurst, Sydney, New South Wales, Australia. 2. School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales (UNSW), Kensington, Sydney, New South Wales, Australia. (1)
1Lester and Sue Smith Breast Center and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA (1)
Agriculture and Agri-Food Canada, Ottawa Research and Development Centre. (1)
Center for Proteomics and Metabolomics Leiden University Medical Center (1)
Center for Proteomics and Metabolomics, Leiden University Medical Center and Proteomics Centre, University of Victoria (1)
Chemistry Department, Duke University (1)
Chemistry Department, Duke University, Durham, NC, 27705, USA (1)
Collaborative Center for Translational Mass Spectrometry, TGen (1)
College of Medicine and Public Health, FHMRI, Flinders University, Australia (1)
Dana-Farber Cancer Institute/ Harvard Medical School (1)
Denali Therapeutics (1)
Department of Biochemistry and Chemistry, Research Centre for Extracellular Vesicles, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3086, Australia (1)
Department of Biological Engineering, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA (1)
Department of Cancer Biology, Dana-Farber Cancer Institute Department of Cell Biology, Harvard Medical School (1)
Department of Cellular and Molecular Pharmacology, University of California San Francisco, USA (1)
Department of Chemistry & Bioscience Aalborg University Denmark (1)
Department of Chemistry, University of California, Riverside 501 Big Springs Rd, Riverside, CA 92521 (1)
Department of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany (1)
Department of Marine, Earth and Atmospheric Sciences, North Carolina State University, Raleigh, NC 27695 (1)
Department of Nutritional Sciences and Toxicology University of California, Berkeley Berkeley, CA (1)
Department of Pathology, Medical University of Vienna, Austria (1)
Department of Physiology, Faculty of Pharmacy, University of Valencia, Burjassot, Valencia, Spain (1)
Departments of Chemistry and Biological Sciences, Vanderbilt University (1)

IsPrivate

False (5)

Modification

Not available (1)

Study type

Transcription profiling by array (116)
RNA-seq of coding RNA (23)
Comparative genomic hybridization by array (6)
Methylation profiling by array (5)
ChIP-chip by tiling array (3)
ChIP-seq (3)
Unknown experiment type (2)
ChIP-chip by array (2)
DNA-seq (2)
High-throughput sequencing (1)
Transcription profiling by tiling array (1)
RIP-seq (1)
Ribo-seq (1)
Other (1)

Release Date

2025 (423)
2022 (410)
2024 (396)
2023 (394)
2021 (385)
2020 (247)
2019 (200)
2018 (152)
2017 (143)
2016 (128)
2015 (119)
2014 (92)
2013 (70)
2012 (68)
2026 (66)
2011 (42)
2009 (36)
2010 (35)
2008 (11)
2007 (10)
2005 (10)
2004 (8)
2006 (6)
2002 (4)
2003 (2)
2001 (2)
2000 (2)
1998 (2)
1999 (1)

Previous page
1 / 360
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 360
Next page

Sort by:

Relevance

Page size

Transcriptomic and Metabolomic Joint Analysis to Explore the Molecular Mechanisms of Different Resistant Poplar Varieties in Response to the Feeding Damage of Anoplophora glabripennis

In China, Asian longhorned beetle (ALB) infestations severely threaten poplar resources, the primary species used for shelterbelt afforestation. Two fast-growing poplar hybrids, Populus alba × (P. alba × P. glandulosa) ...

2026-03-11 | MTBLS14028 | MetaboLights

Lipidomics study of different fat deposition sites in wuzhishan pigs with double knockout of APOE/LDLR

Apolipoprotein E (APOE) and the low-density lipoprotein receptor (LDLR) play a key role in regulating lipoprotein transport and cholesterol homeostasis. However, their roles in porcine fat deposition and adipose tissue remodelling are not well understood. This study utilised wild-type (WT) and APOE/...

2026-09-09 | MTBLS15330 | MetaboLights

Effect of TraN key residues involved in DNA binding on pIP501 transfer rates in Enterococcus faecalis.

Not available

S-EPMC10877727 | biostudies-literature

In situ pelagic dataset from continuous monitoring: A mesocosm experiment in Lake Geneva (MESOLAC).

Not available

S-EPMC7481807 | biostudies-literature

Shotgun metagenomic dataset of root endophytic microbiome of citrus (Citrus nobilis L.).

Not available

S-EPMC11357868 | biostudies-literature

Frequent gene flow blurred taxonomic boundaries of sections in Lilium L. (Liliaceae).

Not available